Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graham

Showing results (861-870 of 994) with videos related to

Pageof 100
Sort By:
ERJ Open Research|February 4, 2020
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthmaMario Castro, Klaus F Rabe, Jonathan Corren, et al.
Nature Communications|September 11, 2015
Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failureSan-Pin Wu, Chung-Yang Kao, Leiming Wang, et al.
Journal of Developmental Origins of Health and Disease|May 20, 2022
Aberrant inflammation in rat pregnancy leads to cardiometabolic alterations in the offspring and intrauterine growth restriction in the F2 generationTakafumi Ushida, Tiziana Cotechini, Nicole Protopapas, et al.
The British Journal of Dermatology|September 24, 2020
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension studyM J Cork, D Thaçi, L F Eichenfield, et al.
Acta Dermato-Venereologica|May 18, 2019
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity IndexLieneke F M Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, et al.
Stroke|March 6, 1999
Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) InvestigatorsR L Wolman, N A Nussmeier, A Aggarwal, et al.
The British Journal of Dermatology|February 22, 2019
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trialsJ I Silverberg, E L Simpson, M Ardeleanu, et al.
Genome Announcements|March 18, 2017
Genome Sequence of Cluster W Mycobacteriophage TapticCatherine M Mageeney, Emily R Seier, Elise C Esposito, et al.
The Journal of Pathology. Clinical Research|December 6, 2016
STAT1-associated intratumoural T<sub>H</sub>1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancerKatrina K Au, Cécile Le Page, Runhan Ren, et al.
Lancet (London, England)|May 1, 2016
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialSally Wenzel, Mario Castro, Jonathan Corren, et al.
Pageof 100

Showing results (861-870 of 994) with videos related to

Sort By:
Pageof 100
ERJ Open Research|February 4, 2020
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthmaMario Castro, Klaus F Rabe, Jonathan Corren, et al.
Nature Communications|September 11, 2015
Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failureSan-Pin Wu, Chung-Yang Kao, Leiming Wang, et al.
Journal of Developmental Origins of Health and Disease|May 20, 2022
Aberrant inflammation in rat pregnancy leads to cardiometabolic alterations in the offspring and intrauterine growth restriction in the F2 generationTakafumi Ushida, Tiziana Cotechini, Nicole Protopapas, et al.
The British Journal of Dermatology|September 24, 2020
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension studyM J Cork, D Thaçi, L F Eichenfield, et al.
Acta Dermato-Venereologica|May 18, 2019
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity IndexLieneke F M Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, et al.
Stroke|March 6, 1999
Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) InvestigatorsR L Wolman, N A Nussmeier, A Aggarwal, et al.
The British Journal of Dermatology|February 22, 2019
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trialsJ I Silverberg, E L Simpson, M Ardeleanu, et al.
Genome Announcements|March 18, 2017
Genome Sequence of Cluster W Mycobacteriophage TapticCatherine M Mageeney, Emily R Seier, Elise C Esposito, et al.
The Journal of Pathology. Clinical Research|December 6, 2016
STAT1-associated intratumoural T<sub>H</sub>1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancerKatrina K Au, Cécile Le Page, Runhan Ren, et al.
Lancet (London, England)|May 1, 2016
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialSally Wenzel, Mario Castro, Jonathan Corren, et al.
Pageof 100